Food ingredients manufacturer Vertellus has announced the acquisition of Jarchem Innovative Ingredients for an undisclosed sum.
Jarchem is a manufacturer and supplier of speciality chemicals and nature-based materials, that produces food ingredients for a wide variety of applications, including in dairy, baking, flavouring, and wine and beer filtration.
The acquisition will help to expand Vertellus’s environmentally friendly ingredients offering, as well as grow its customer base.
“The Jarchem team is thrilled to partner with Vertellus to bring our compelling product portfolio to more customers around the world,” said Jarchem’s managing director, Art Hein. “As consumers increasingly seek natural, healthy alternatives to conventional products, together our companies are well-positioned for long-term growth.”
Thomas Chadwick, principal at Pritzker Private Capital, which owns Vertellus, added: “This acquisition extends Vertellus’s strategic priority to further strengthen its portfolio of innovative speciality ingredients. The combined company has an attractive position in high-growth markets and is poised for continued, long-term success.”
By Rafaela Sousa
Source: foodbev.com
The Hershey Company has formally announced a leadership succession plan as Michele Buck, the current chairman, president and CEO, prepares to retire on June 30 2026. Buck, who has been with the company for two decades, will remain in her roles until a successor is appointed, after which she will transition to a senior advisor position.
The Kraft Heinz Company has officially appointed Marta Pilczuk as the managing director for its UK and Ireland operations, effective from January 1 2025. Pilczuk, who has over 16 years of experience in the fast-moving consumer goods (FMCG) sector, steps into this role following a successful tenure as managing director of Kraft Heinz Poland.
The US Food and Drug Administration (FDA) has banned the use of the synthetic colourant Red Dye 3 in food, beverages and ingested drugs. The decision, announced on 15 January 2025, follows two studies that linked the dye to cancer in male laboratory rats.
